ES2139602T3 - Composiciones oculares que contienen esteroides y su utilizacion para el tratamiento del glaucoma. - Google Patents
Composiciones oculares que contienen esteroides y su utilizacion para el tratamiento del glaucoma.Info
- Publication number
- ES2139602T3 ES2139602T3 ES92912769T ES92912769T ES2139602T3 ES 2139602 T3 ES2139602 T3 ES 2139602T3 ES 92912769 T ES92912769 T ES 92912769T ES 92912769 T ES92912769 T ES 92912769T ES 2139602 T3 ES2139602 T3 ES 2139602T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- glaucoma
- treatment
- date
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION SE REFIERE AL DOMINIO DE LA QUIMICA TERAPEUTICA. CONCIERNE MAS EN PARTICULAR AL DE LA REALIZACION DE COMPOSICIONES FARMACEUTICAS PARA LA APLICACION OCULAR. TIENE POR OBJETO UNAS COMPOSICIONES FARMACEUTICAS PARA LA APLICACION OCULAR CARACTERIZADAS EN QUE ENCIERRAN AL MENOS UN COMPUESTO DE ESTRUCTURA ESTEROIDIANA SELECCIONADA EN ASOCIACION O EN MEZCLA CON UN EXCIPIENTE O UN VEHICULO INERTE FARMACEUTICAMENTE ACEPTABLE. LAS COMPOSICIONES SEGUN LA INVENCION ESTAN DIRIGIDAS PARA EL TRATAMIENTO DE LA GLAUCOMA.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9107412 | 1991-06-18 | ||
FR9109016A FR2679138B1 (fr) | 1991-07-17 | 1991-07-17 | Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention. |
FR9109017A FR2679139B1 (fr) | 1991-07-17 | 1991-07-17 | Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation. |
FR9109015A FR2679137B1 (fr) | 1991-07-17 | 1991-07-17 | Nouvelles compositions pharmaceutiques a base d'un derive pregnenique et leur procede de preparation. |
FR9110160A FR2680108B1 (fr) | 1991-08-09 | 1991-08-09 | Nouvelles compositions pharmaceutiques a base de sterouides 6-hydroxymethyles et leur procede d'obtention. |
PCT/FR1992/000549 WO1992022300A1 (fr) | 1991-06-18 | 1992-06-18 | Compositions oculaires contenant des steroïdes et leur utilisation pour le traitement du glaucome |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2139602T3 true ES2139602T3 (es) | 2000-02-16 |
Family
ID=27515565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92912769T Expired - Lifetime ES2139602T3 (es) | 1991-06-18 | 1992-06-18 | Composiciones oculares que contienen esteroides y su utilizacion para el tratamiento del glaucoma. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5506220A (es) |
EP (1) | EP0593520B1 (es) |
JP (1) | JP3328729B2 (es) |
KR (1) | KR100249555B1 (es) |
AT (1) | ATE185071T1 (es) |
CA (1) | CA2111699A1 (es) |
DE (1) | DE69230069T2 (es) |
DK (1) | DK0593520T3 (es) |
ES (1) | ES2139602T3 (es) |
GR (1) | GR3031967T3 (es) |
WO (1) | WO1992022300A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004229291A1 (en) * | 2003-04-18 | 2004-10-28 | Advanced Medicine Research Institute | Remedies for diseases to be applied to eye |
WO2004093882A1 (ja) * | 2003-04-18 | 2004-11-04 | Advanced Medicine Research Institute | 眼に適用する疾患治療剤 |
EP2468318A1 (en) * | 2005-07-12 | 2012-06-27 | DMI Biosciences, Inc. | Methods and products for treatment of diseases |
EP2445350A4 (en) * | 2009-06-22 | 2012-12-26 | Dmi Acquisition Corp | METHOD AND PRODUCTS FOR THE TREATMENT OF DISEASES |
DK2326332T3 (da) | 2009-06-22 | 2013-03-04 | Dmi Acquistion Corp | Fremgangsmåde til behandling af sygdomme |
CN102134265B (zh) * | 2009-12-29 | 2013-04-03 | 黄云生 | 一种合成6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法 |
PT2709631T (pt) | 2011-05-20 | 2017-04-19 | Inserm - Inst Nat De La Santé Et De La Rech Médicale | Antagonistas de receptor de cb1 |
CA2892347C (en) | 2012-11-28 | 2019-04-02 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone |
WO2014100352A1 (en) | 2012-12-19 | 2014-06-26 | Ampio Pharmaceuticals, Inc. | Method for treatment of diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1515284A (en) * | 1974-05-21 | 1978-06-21 | Gastaud J | Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series |
US4383992A (en) * | 1982-02-08 | 1983-05-17 | Lipari John M | Water-soluble steroid compounds |
US4617299A (en) * | 1983-12-19 | 1986-10-14 | Knepper Paul A | Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension |
US4863912A (en) * | 1986-05-19 | 1989-09-05 | New York Medical College | Use of tetrahydrocortisol in glaucoma therapy |
WO1987007141A1 (en) * | 1986-05-23 | 1987-12-03 | New England Medical Center Hospitals, Inc. | Method for treating glaucoma |
FR2622194B1 (fr) * | 1987-10-27 | 1990-03-23 | Theramex Laboratoire | Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant |
US4876250A (en) * | 1988-10-31 | 1989-10-24 | Alcon Laboratories, Inc. | Methods for controlling ocular hypertension with angiostatic steroids |
FR2645864B1 (fr) * | 1989-04-13 | 1991-07-12 | Theramex | Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
FR2679236B1 (fr) | 1991-07-18 | 1997-01-24 | Theramex | Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant. |
-
1992
- 1992-06-18 DK DK92912769T patent/DK0593520T3/da active
- 1992-06-18 US US08/170,179 patent/US5506220A/en not_active Expired - Fee Related
- 1992-06-18 EP EP92912769A patent/EP0593520B1/fr not_active Expired - Lifetime
- 1992-06-18 AT AT92912769T patent/ATE185071T1/de not_active IP Right Cessation
- 1992-06-18 CA CA002111699A patent/CA2111699A1/fr not_active Abandoned
- 1992-06-18 DE DE69230069T patent/DE69230069T2/de not_active Expired - Fee Related
- 1992-06-18 ES ES92912769T patent/ES2139602T3/es not_active Expired - Lifetime
- 1992-06-18 JP JP50077393A patent/JP3328729B2/ja not_active Expired - Fee Related
- 1992-06-18 KR KR1019930703965A patent/KR100249555B1/ko not_active IP Right Cessation
- 1992-06-18 WO PCT/FR1992/000549 patent/WO1992022300A1/fr active IP Right Grant
-
1999
- 1999-11-26 GR GR990403060T patent/GR3031967T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1992022300A1 (fr) | 1992-12-23 |
GR3031967T3 (en) | 2000-03-31 |
DE69230069T2 (de) | 2000-05-25 |
ATE185071T1 (de) | 1999-10-15 |
JP3328729B2 (ja) | 2002-09-30 |
CA2111699A1 (fr) | 1992-12-23 |
EP0593520B1 (fr) | 1999-09-29 |
DE69230069D1 (de) | 1999-11-04 |
EP0593520A1 (fr) | 1994-04-27 |
KR940701260A (ko) | 1994-05-28 |
KR100249555B1 (ko) | 2000-04-01 |
DK0593520T3 (da) | 2000-04-03 |
US5506220A (en) | 1996-04-09 |
JPH06508362A (ja) | 1994-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE184598T1 (de) | Enniatine und enniatinderivate zur bekämpfung von endoparasiten | |
ES2061252T3 (es) | Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. | |
ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
ECSP034815A (es) | "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas" | |
NO931766L (no) | Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin | |
KR960701051A (ko) | 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases) | |
KR930012022A (ko) | 뇌조직 보호용 모다피닐(Modafinil) | |
ES2154262T3 (es) | Uso de compuestos macrolidos para enfermedades oculares. | |
DE69221640D1 (de) | Topisches mittel gegen freie radikale, das superoxyd-dismutase und ein phosphonsäurederivat enthält | |
DE60040753D1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
ES2139602T3 (es) | Composiciones oculares que contienen esteroides y su utilizacion para el tratamiento del glaucoma. | |
ZA947957B (en) | Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them | |
ATE152628T1 (de) | Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft | |
BR0108219A (pt) | Uso oftálmico de agentes bloqueadores alfa-adrenérgicos | |
AR004474A1 (es) | Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen | |
AU7000794A (en) | Use of corrinoids in topical treatment of skin diseases | |
ES2147796T3 (es) | Composicion para el tratamiento o la prevencion del herpes. | |
KR960700711A (ko) | 뇌혈관성 질환의 치료 또는 예방용 약제(Medicament for treating or preventing cerebrovascular diseases) | |
SE8901149D0 (sv) | Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat | |
KR910002455A (ko) | 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용 | |
ES2072005T3 (es) | Utilizacion de analogos de 20(r)-22-oxa-vitamina d en la preparacion de un medicamento para el tratamiento del envejecimiento de la piel. | |
ES2114678T3 (es) | Composiciones farmaceuticas que comprenden compuestos de contignasterol. | |
KR900017599A (ko) | 종양 치료용 약학 조성물 | |
EP0992242A4 (en) | PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS | |
AU5625194A (en) | Rectal flunisolide compositions for treating inflammatory intestinal disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 593520 Country of ref document: ES |